We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$702M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.35% |
| 3 | Financials | 13.74% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Schwab US Mid-Cap ETF
SCHM
$14.5B
| $1.39M | ﹤0.01% |
95,559
+57,162
| +149% | +$827K |
|
552
EQT Corp
EQT
$32.3B
| $1.38M | ﹤0.01% |
35,006
+316
| +0.9% | +$12.5K |
|
|
BCR
553
DELISTED
CR Bard Inc.
BCR
| $1.38M | ﹤0.01% |
6,139
+3,048
| +99% | +$686K |
|
554
Boston Properties
BXP
$11.2B
| $1.38M | ﹤0.01% |
10,092
-20
| -0.2% | -$2.78K |
|
|
LLTC
555
DELISTED
Linear Technology Corp
LLTC
| $1.37M | ﹤0.01% |
23,126
-1,252
| -5% | -$70.2K |
|
556
Waters Corp
WAT
$37.7B
| $1.35M | ﹤0.01% |
8,507
+950
| +13% | +$147K |
|
557
Archer Daniels Midland
ADM
$40.1B
| $1.34M | ﹤0.01% |
31,703
-1,791
| -5% | -$77.4K |
|
|
MACK
558
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.33M | ﹤0.01% |
26,728
| – | – |
|
559
Hershey
HSY
$37.2B
| $1.33M | ﹤0.01% |
13,957
+616
| +5% | +$65.2K |
|
|
TFCF
560
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $1.33M | ﹤0.01% |
53,850
+39,700
| +281% | +$1.03M |
|
561
Nucor
NUE
$60.5B
| $1.33M | ﹤0.01% |
26,803
+15,079
| +129% | +$767K |
|
|
PXD
562
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.33M | ﹤0.01% |
7,137
+32
| +0.5% | +$5.45K |
|
563
Agilent Technologies
A
$39.7B
| $1.31M | ﹤0.01% |
27,867
| – | – |
|
564
Hubbell
HUBB
$25.6B
| $1.31M | ﹤0.01% |
12,166
+2,507
| +26% | +$266K |
|
565
Factset
FDS
$10.1B
| $1.31M | ﹤0.01% |
8,080
+878
| +12% | +$151K |
|
566
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $1.3M | ﹤0.01% |
31,390
+9,839
| +46% | +$400K |
|
|
NVO
567
Novo Nordisk
NVO
$225B
| $1.3M | ﹤0.01% |
62,324
-5,098
| -8% | -$126K |
|
568
Omega Healthcare
OHI
$15.4B
| $1.28M | ﹤0.01% |
36,086
+9,040
| +33% | +$321K |
|
569
Unilever
UL
$144B
| $1.27M | ﹤0.01% |
23,820
+5,015
| +27% | +$265K |
|
570
iShares Select Dividend ETF
DVY
$24.1B
| $1.27M | ﹤0.01% |
14,771
+435
| +3% | +$37.5K |
|
571
Arrow Electronics
ARW
$10.8B
| $1.25M | ﹤0.01% |
19,520
| – | – |
|
572
TotalEnergies
TTE
$187B
| $1.24M | ﹤0.01% |
26,062
-7,407
| -22% | -$354K |
|
573
American Electric Power
AEP
$72.4B
| $1.24M | ﹤0.01% |
19,275
+58
| +0.3% | +$3.9K |
|
574
Check Point Software Technologies
CHKP
$14.1B
| $1.24M | ﹤0.01% |
15,930
-127,717
| -89% | -$9.91M |
|
575
Welltower
WELL
$172B
| $1.24M | ﹤0.01% |
16,528
+733
| +5% | +$56.1K |
|
Similar funds
QCM
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.